BUMC Featured Funding Opportunities

Department of Defense Health Research Programs – Event Slides and Video

October 31st, 2014

In September 2014, BU’s Government Relations office hosted  Michael Ledford, Vice President, Lewis-Burke Associates LLC, who delivered  a presentation on the Department of Defense Health Research Programs.

The presentation covered current cross-cutting trends and priorities, specific DOD programs which engage most directly with university researchers, and techniques for navigating the DOD health landscape. The presentation reviewed more than 15 targets for research, including the Army Medical Research and Materiel Command, the Congressionally Directed Medical Research Program, the Defense Medical Research and Development Program, the Defense Advanced Research Projects Agency, and the Defense Threat Reduction Agency.

If you missed the live presentation, the slides and video from the event are now available  for your viewing. Please note, you will need your Kerberos credentials to view both files.

Department of Defense Health Research: Navigating the Funding Landscape

 

Dan David Prize – Due Nov 30th

October 20th, 2014

The Dan David Prize, a joint international enterprise endowed by the Dan David Foundation and headquartered at Tel Aviv University, aims to foster universal values of excellence, creativity, justice, democracy, and progress and to promote the scientific, technological, and humanistic achievements that advance and improve our world. The Prize covers three time dimensions – Past, Present, and Future – that represent realms of human achievement. The Past refers to fields that expand knowledge of former times. The Present recognizes achievements that shape and enrich society today. The Future focuses on breakthroughs that hold great promise for improvement of our world.

The themes for the 2015 competition cycle are:

  • Past – Retrieving the Past: Historians and their Sources
  • Present – The Information Revolution
  • Future – Bioinformatics

FUNDING INFORMATION:
One million dollars per each field.

ELIGIBILITY RESTRICTIONS:

  • Nominees may be individuals or organizations. Specific and unique projects may be included if the head of the project is a nominee.
  • The individual or institution being nominated must have made a unique, profound contribution to humanity, on a global scale, in one of the selected fields.
  • The work for which a nominee’s recognition is sought may represent a singular achievement, a series of achievements, or a life’s work.
  • An individual or organization can only receive the Prize once for the same achievement and/or contribution.
  • Self-nominations will not be accepted.

NOMINATION PROCESS:
Nomination guidelines are available at: http://www.dandavidprize.org/prize-nominations
The nomination form may be accessed at: http://www.dandavidprize.org/nomination-form

DEADLINE:
Sponsor Deadline: Sunday, November 30, 2014

Free-to-Breathe Research Grant: LOI due Nov 7th

September 16th, 2014

Free to Breathe has a new funding opportunity solely focused on research to prevent or stop lung cancer metastasis. The foundation will only consider Letters of Intent proposing research to prevent or stop lung cancer metastasis including a clear vision and plan for clinical translation within three years.

Key dates

  • Letter of intent deadline: November 7th, 2014
  • Invitation for submission of full application: January 7th, 2015
  • Full application deadline: March 9th, 2015
  • Applicant notification: May 15th, 2015
  • Anticipated funding start date: June 1st, 2015

Visit the Free to Breathe website more information.

Partnerships for International Research and Education Program (PIRE)

August 8th, 2014

DEADLINES:

  • Internal Deadline:  September 8, 2014
  • NSF Preliminary Proposal Deadline:  October 21, 2014
  • Final Proposals (by invitation) Deadline:  May 15, 2015

PROGRAM  DESCRIPTION:  

Partnerships for International Research and Education (PIRE) is an NSF-wide program that supports international activities across all NSF supported disciplines. The primary goal of PIRE is to support high quality projects in which advances in research and education could not occur without international collaboration. PIRE seeks to catalyze a higher level of international engagement in the U.S. science and engineering community.  PIRE promotes excellence in science and engineering through international collaboration and facilitates development of a diverse, globally-engaged, U.S. science and engineering workforce.

This PIRE competition will be open to all areas of science and engineering research which are supported by the NSF.

ELIGIBILITY:

There are no restrictions or limits on who can serve as a PI as long as they have or request PI status through Boston University. Proposals may be submitted by U.S. academic institutions with Ph.D.-granting programs that have awarded doctoral degrees in the 2012 or 2013 academic years in any area of research supported by NSF. Note that universities are limited to one proposal as the lead institution. There is no limit on the number of proposals in which an institution can participate as a partner. Full proposals will be accepted by invitation only. For the purposes of this opportunity, Boston University and Boston University Medical Campus will be considered separate institutions allowing one preliminary proposal from each.

FUNDING INFORMATION:

NSF intends to award a total of $10 million-$15 million for this round of PIRE. Pending the availability of funds, NSF will make average awards of approximately $4 million over five years. Additional funding for international partners on PIRE projects may be available from selected NSF counterpart agencies abroad.

WEB:http://www.nsf.gov/pubs/2014/nsf14587/nsf14587.htm

APPLICATION  PROCESS:

BUMC may submit only one application to the PIRE program.  Potential applicants will be reviewed internally to select the final candidate.  If you would like to apply, please email the following documents (preferably combined into a single pdf file) to Diana Lehman (dlehman@bu.edu), Office of Clinical Research by September 8, 2014:

  • a one-page project summary describing the concept of the proposed PIRE project, including why the international partnership is critical to the project success and the broader impacts of the project
  • Junior faculty (instructors and assistant professors should include a support letter from their research mentors
  • your email address and your mentor’s email address
  • your biosketch or cv

CDMRP DoD Clinical and Rehabilitative Medicine Research Program

July 21st, 2014

Reconstructive Transplantation Research Funding Opportunity for Fiscal Year 2014

One notable addition in the recent Fiscal year 2014 (FY14) Defense Appropriations Act is $15 million (M) to the Department of Defense for the Reconstructive Transplantation Research Program (RTR) to support the science and execution of complex limb and face transplants. This program is administered by the US Army Medical Research and Materiel Command, the Clinical and Rehabilitative Medicine Research Program (CRMRP), through the Office of Congressionally Directed Medical Research Programs (CDMRP) and the Tissue Injury and Regenerative Medicine Project Management Office. News release was issued on June 20, 2014.
No actual Request for Applications is open yet.  More on this program:  http://cdmrp.army.mil/pubs/press/2014/14rtrppreann.shtml

DoD, VA approve $45 million to fund the Consortium to Alleviate PTSD

July 21st, 2014

The Consortium to Alleviate PTSD has a Request for Applications (RFA) out for funding affiliated with their award. Detailed descriptions of the CAP funding opportunity, evaluation criteria, and submission requirements can be found in the Request for Applications available electronically for downloading from the CAP website

PhRMA September 1, 2014 Funding Opportunities

July 17th, 2014

Over the past 49 years, the PhRMA Foundation has helped thousands of scientists advance their careers and has inspired new generations to enter biopharmaceutical research. The early-career support provided by the PhRMA Foundation has been a catalyst for our scientists to become leaders in their organizations and fields. Our programs help build a larger pool of highly-trained researchers to meet the growing needs of academic institutions, the government and the research-intensive pharmaceutical industry.

The PhRMA Foundation funds scientists at critical points in their research careers to support and reward innovation in disciplines essential to the development of safe and effective medicines. The PhRMA Foundation offers competitive pre and post doctoral fellowships, sabbatical fellowships, and research starter grants to advance science in pharmacology, toxicology, informatics, pharmaceutics, and health outcomes. The Foundation also offers a Comparative Effectiveness Research Center of Excellence Award.

PhRMA Foundation award recipients will continue to play an instrumental role in substantial achievements in medicine for the benefit of public health and ultimately the patient.

BUMC Transgenic Core has a New Scientific Director

July 14th, 2014

The BUMC Transgenic Core, established in 1995 by Dr. Katya Ravid, has played an important role in the activities of many scientists at our institution. As part of the continual evaluation of all cores, a faculty committee was established to advise Provost Antman and me on the future role of transgenic services at BUMC.

The committee members were unanimously in favor of maintaining a Transgenic Core facility at BU and increasing its capabilities to serve a larger user group. While the committee recognized that implementation of this recommendation will require new investment at a time of fiscal uncertainty, they were convinced that a transgenic core providing state-of-the-art services is essential for maintaining and growing the University’s research portfolio.

After careful consideration of her many leadership commitments, Dr. Ravid has chosen to step down as Scientific Director of the core because of conflicting time commitments. We would like to thank Dr. Ravid for her creative work and efforts on behalf of the institution in establishing and directing the core over the past 20 years. Her insights and efforts contributed to the success of many research projects and grants at BU.

Dr. Kenn Albrecht, a developmental geneticist with broad expertise in the creation and analysis of mouse models of human disease and a collaborator of Dr. Ravid and the Transgenic Core on multiple projects, has agreed to become the new Scientific Director. Please join me in thanking Dr. Ravid for her efforts and Dr. Albrecht for continuing the mission of the Transgenic Core Facility.

Posted in New Posts

BWF Pathogenesis of Infectious Disease Program – BU internal deadline September 9, 2014

July 9th, 2014

Limited Submission Opportunity: Burroughs Wellcome Fund Program for Investigators in the Pathogenesis of Infectious Disease

The Burroughs Wellcome Fund has announced its Investigators in the Pathogenesis of Infectious Disease funding program.  This award provides $500,000 over a period of five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters. The awards are intended to give recipients the freedom and flexibility to pursue new avenues of inquiry and higher-risk research projects that hold potential for significantly advancing the biochemical, pharmacological, immunological, and molecular biological understanding of how microbes and the human body interact.

PROGRAM DESCRIPTION:The Investigators in the Pathogenesis of Infectious Disease program provides opportunities for assistant professors to bring multidisciplinary approaches to the study of human infectious diseases. Areas of particular interest include:

  • Cell/Pathogen interactions—studies of host responses at the cell surface, cell signaling in response to infection, microbial persistence in host cells, and other work.
  • Host/Pathogen interactions—studies of how host genetics influences resistance and susceptibility to infection, innate and adaptive immune responses to microbes, pathogen modulation of the immune system, and other work.
  • Novel routes to disease causation—studies of the role of infectious agents in the etiology of chronic, autoimmune, and immunologic diseases, and other work.

ELIGIBILITY: Candidates must be nominated by accredited, degree-granting institutions in the United States or Canada. A U.S. or Canadian institution, including its medical school, graduate schools, and all affiliated hospitals and research institutes, may nominate up to two candidates. However, institutions that nominate a candidate who holds a Doctorate of Veterinary Medicine (D.V.M.) will be allowed three nominations.  Institutions may have a single additional nomination if they nominate a researcher working in pathogenic helminthes, mycology, or reproductive science. Institutions may have one additional nomination if they nominate a member of an underrepresented minority group.

Candidates will generally have an M.D., D.V.M., or Ph.D. degree and must be citizens or permanent residents of the United States or Canada at the time of application. Candidates must have an established record of independent research and hold a tenure-track position as an assistant professor or equivalent at the time of application.

FUNDING INFORMATIONThis award provides $500,000 over a period of five years. No more than $20,000 of the award may be used annually for the grantee’s salary support, including fringe benefits. Indirect costs may not be charged against the award. Grantees must devote at least 75 percent of their time to research-related activities.

AGENCY CONTACT:
Jean Kramarik, Senior Program Associate
Burroughs Wellcome Fund
21 T. W. Alexander Drive
Research Triangle Park, NC 27709
Telephone: 919-991-5122
Email: jkramarik@bwfund.org
Web:   http://www.bwfund.org/grant-programs/infectious-diseases/investigators-pathogenesis-infectious-disease

DEADLINES:
BU Internal Deadline: September 9, 2014
Nomination Deadline: November 3, 2014

INTERNAL REVIEW PROCESS:  Boston University may nominate two candidates for the award.  An internal review committee will select the final nominees.  If you would like to apply, please send the following documents, combined into single pdf file, to Diana Lehman (dlehman@bu.edu) by September 9, 2014:  

  •  A one-page summary of your research
  •  A letter from your research mentor or departmental chair
  •  Your email address and your mentor’s email address
  •  The exact date of your first faculty appointment
  •  Your CV

BUMC survey on Lab Notebooks

July 9th, 2014

A lab notebook is the primary record of research, where scientists document their hypotheses, experiments and initial analysis or interpretation of experiments. The lab notebook serves primarily as a memory aid and a legacy document for future scientific experiments. It is important to understand that a lab notebook is a legal document, which in case of allegations of misconduct or patent disputes, is used to validate a scientist’s findings. Despite its legal significance, there is no established universal standard for the use of lab notebooks.

The purpose of this survey is to learn what types of laboratory notebooks are currently used at BUMC, as well as to determine whether BU should develop guidelines or establish policies regarding the composition of laboratory notebooks campus-wide.

Please take a few minutes to fill out this survey by clicking on the link below:

https://bostonu.qualtrics.com/SE/?SID=SV_erPGpM97KtaO8vz

Your responses will be anonymous.  We will only collect some general demographic information from you to make sure the survey represents an adequate cross section of schools, departments and functions at BUMC.

Thank you for your cooperation!

Posted in Uncategorized

Approaching Deadlines BUMC Featured Funding Opportunities